379PRISK FACTORS FOR DEVELOPING SKELETAL-RELATED EVENTS ASSOCIATED WITH METASTATIC BREAST CANCER PATIENTS RECEIVING BONE-MODIFYING AGENTS
Tanaka, R., Yonemori, K., Hirakawa, A., Hashimoto, J., Kodaira, M., Yamamoto, H., Yunokawa, M., Shimizu, C., Fujimoto, M., Fujiwara, Y., Tamura, K.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu329.28
Date:
September, 2014
File:
PDF, 59 KB
2014